1,628
Views
13
CrossRef citations to date
0
Altmetric
Brief Report

Synthesis and biological evaluation of new 3(2H)-pyridazinone derivatives as non-toxic anti-proliferative compounds against human colon carcinoma HCT116 cells

, , , ORCID Icon, , , , , & show all
Pages 1100-1109 | Received 12 Mar 2020, Accepted 08 Apr 2020, Published online: 22 Apr 2020

References

  • Vogelstein A, Kinzler KW. The multistep nature of cancer. Trends Genet 1993;9:38–41.
  • Smith RA, Andrews KS, Brooks D, et al. Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 2019;69:184–210.
  • Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019;144:1941–53.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70:7–30.
  • Banerjee PS. Various biological activities of pyridazinone ring derivatives. Asian J Chem 2011;23:1905–10.
  • Yamali C, Ozan GH, Kahya B, et al. Synthesis of some 3(2H)-pyridazinone and 1(2H)-phthalazinone derivatives incorporating aminothiazole moiety and investigation of their antioxidant, acetylcholinesterase, and butyrylcholinesterase inhibitory activities. Med Chem Res 2015;24:1210–17.
  • Utku S, Gökçe M, Aslan G, et al. Synthesis and in vitro antimycobacterial activities of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/nonsubstituted acetophenone)hydrazone. Turk J Chem 2011;61:1–9.
  • Şahina MF, Badıçoglu B, Gökçe M, et al. Synthesis and analgesic and antiinflammatory activity of methyl[6-substituted-3(2H)-pyridazinone-2-yl]acetate derivatives. Arch Pharm Pharm Med 2004;337:445–52.
  • Siddiqui AA, Mishra R, Shaharyar M, et al. Triazole incorporated pyridazinones as a new class of antihypertensive agents: design, synthesis and in vivo screening. Bioorg Med Chem Lett 2011;21:1023–6.
  • Siddiqui AA, Mishra R, Shaharyar M. Synthesis, characterization and antihypertensive activity of pyridazinone derivatives. Eur J Med Chem 2010;45:2283–90.
  • Özçelik AB, Özdemir Z, Sari S, et al. A new series of pyridazinone derivatives as cholinesterases inhibitors: synthesis, in vitro activity and molecular modeling studies. Pharmacol Rep 2019;71:1253–63.
  • Nagle P, Pawar Y, Sonawane A, et al. Docking simulation, synthesis and biological evaluation of novel pyridazinone containing thymol as potential antimicrobial agents. Med Chem Res 2014;23:918–26.
  • Bruel A, Logé C, Tauzia ML, et al. Synthesis and biological evaluation of new 5-benzylated 4-oxo-3,4-dihydro-5H-pyridazino[4,5-b]indoles as PI3Kα inhibitors. Eur J Med Chem 2012;57:225–33.
  • Özdemir Z, Başak-Türkmen N, Ayhan İ, et al. Synthesis of new 6-[4-(2-fluorophenylpiperazine-1-yl)]-3(2H)-pyridazinone-2-acethyl-2-(substitutedbenzal)hydrazone derivatives and evulation of their cytotoxic effects in liver and colon cancer cell line. Pharm Chem J 2019;52:923–9.
  • Çiftçi O, Özdemir Z, Acar C, et al. The novel synthesized pyridazinone derivates had the antiproliferative and apoptotic effects in SHSY5Y and HEP3B cancer cell line. Lett Org Chem 2018;15:323–31.
  • Rathish IG, Javed K, Ahmad S, et al. Synthesis and evaluation of anticancer activity of some novel 6-aryl-2-(p-sulfamylphenyl)-pyridazin-3(2H)-ones. Eur J Med Chem 2012;49:304–9.
  • Marconi GD, Carradori S, Ricci A, et al. Kinesin Eg5 targeting inhibitors as a new strategy for gastric adenocarcinoma treatment. Molecules 2019;24:3948.
  • Marconi GD, Gallorini M, Carradori S, et al. The up-regulation of oxidative stress as a potential mechanism of novel MAO-B inhibitors for glioblastoma treatment. Molecules 2019;24:2005.
  • Kuchuk O, Tuccitto A, Citterio D, et al. pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma. Oncoimmunology 2018;7:e1445452.
  • Ferrante C, Recinella L, Ronci M, et al. Multiple pharmacognostic characterization on hemp commercial cultivars: focus on inflorescence water extract activity. Food Chem Toxicol 2019;125:452–61.
  • Di Giacomo V, Chiavaroli C, Orlando G, et al. Neuroprotective and neuromodulatory effects induced by cannabidiol and cannabigerol in rat Hypo-E22 cells and isolated hypothalamus. Antioxidants 2020;9:71.
  • Regmi SC, Park SY, Ku SK, Kim JA. Serotonin regulates innate immune responses of colon epithelial cells through Nox2-derived reactive oxygen species. Free Radic Biol Med 2014;69:377–89.
  • Ballou Y, Rivas A, Belmont A, et al. 5-HT serotonin receptors modulate mitogenic signaling and impact tumor cell viability. Mol Clin Oncol 2018;9:243–54.
  • Curtis JJ, Seymour CB, Mothersill CE. Cell line-specific direct irradiation and bystander responses are influenced by fetal bovine serum serotonin concentrations. Radiat Res 2018;190:262–70.
  • Tsai FM, Wu CC, Shyu RY, et al. Tazarotene-induced gene 1 inhibits prostaglandin E2-stimulated HCT116 colon cancer cell growth. J Biomed Sci 2011;18:88.
  • Notarangelo FM, Beggiato S, Schwarcz R. Assessment of prenatal kynurenine metabolism using tissue slices: focus on the neosynthesis of kynurenic acid in mice. Dev Neurosci 2019;41:102–11.
  • Fukui S, Schwarcz R, Rapoport SI, et al. Blood–brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem 1991;56:2007–17.
  • Maddison DC, Giorgini F. The kynurenine pathway and neurodegenerative disease. Semin Cell Dev Biol 2015;40:134–41.
  • Oláh G, Herédi J, Menyhárt A, et al. Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood-brain barrier permeability. Drug Des Devel Ther 2013;7:981–7.
  • Marciniak S, Wnorowski A, Smolińska K, et al. Kynurenic acid protects against thioacetamide-induced liver injury in rats. Anal Cell Pathol (Amst) 2018;2018:1–11.
  • Walczak K, Deneka-Hannemann S, Jarosz B, et al. Kynurenic acid inhibits proliferation and migration of human glioblastoma T98G cells. Pharmacol Rep 2014;66:130–6.
  • Walczak K, Turski WA, Rajtar G. Kynurenic acid inhibits colon cancer proliferation in vitro: effects on signaling pathways. Amino Acids 2014;46:2393–401.
  • Walczak K, Turski WA, Rzeski W. Kynurenic acid enhances expression of p21 Waf1/Cip1 in colon cancer HT-29 cells. Pharmacol Rep 2012;64:745–50.